CD8A and melanoma: Therefore, in the current study we investigated the effects of ipilimumab on the gene expression profile of CD4+ and CD8+ T cells by microarray analysis when it was administered as adjuvant therapy to 12 patients in a trial for patients with high risk resected melanoma.